The global nasal spray market is expected to register high growth in the forecoming years.
The global nasal spray market is expected to register high growth in the forecoming years. One of the major factor driving growth of the global nasal spray markets is rising cases of nasal infection across the globe. In addition, increasing demand for painless drug delivery system, growing aging population, etc. are factors that are expected to drive growth of the global nasal spray market.
The global nasal spray market report has been segmented on the basis of type, container design, dosage form, and region.
On the basis of type, the global nasal spray market has been segmented decongestant nasal spray, saline nasal spray, and steroid nasal spray. The decongestant nasal spray segment is expected to dominate the market in terms of revenue, owing to high usage of nasal spray for treatment of decongestion in respiratory tract, during the forecast period.
On the basis of container type, the global nasal spray market has been segmented pressurized canisters and pump bottles.
On the basis of dosage form, the global nasal spray market has been segmented into unit/single dose, bi/dose, and multi-dose.
On the basis of region, the global nasal spray markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
In 2018, North America nasal spray market accounted for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period, due to increasing prevalence of chronic obstructive pulmonary disease(COPD) across the country in these region. However, Asia Pacific nasal spray market is projected to register highest CAGR in the next five years owing to, and increasing level of pollution which may led to respiratory infections in this region.
For Better Understanding, Download Free Sample Copy Of This Research At: https://marketresearch.biz/report/nasal-spray-market/request-sample/
Key players operating in the global nasal spray market include Sandoz international GmBH, Pfizer Inc., AptarGroup, Inc., Nastech Pharmaceutical Company Inc., Adapt Pharma Inc., Mylan N.V, Innovus Pharmaceuticals, Inc., Allergan PLC, Cipla Limited, and Meda pharmaceuticals, Inc.